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The metabolism of glutamine and glutamate, two important amino acids synthesized in 47 
the human body, may have an etiologic role in melanoma, an aggressive skin malignancy.1, 2 Pre-48 
clinical experiments and clinical trials have demonstrated that metabotropic glutamate receptor 1 49 
blocker and glutamate-release inhibitor (e.g., Riluzole) can suppress melanoma cell migration, 50 
invasion, and proliferation.2 Additionally, inhibiting glutaminase, the enzyme that converts 51 
glutamine to glutamate, further reduced glutamate bioavailability and suppressed tumor 52 
progression.1 Susceptibility to sunburn, a pigmentary trait, is a well-known risk factor for 53 
melanoma.3 However, it is unclear whether plasma glutamate and glutamine are affected by this 54 
host factor even before cancer onset.  55 
We hypothesized plasma glutamate/glutamine levels may differ by individuals’ sunburn 56 
susceptibility. To test this hypothesis, we examined the association among 9,129 women from 57 
previous case-control studies nested within the Nurses’ Health Study (NHS) I (n=5,981) and II 58 
(n=3,148).4 Non-whites and participants with a history of skin cancer or any other malignancy 59 
prior to blood collection were excluded. Information on skin reaction after two or more hours’ 60 
sun exposure as a child/adolescent was collected and grouped into four categories (i.e., 61 
none/some redness only, burn, painful burn, painful burn with blisters). Plasma glutamate and 62 
glutamine concentrations were obtained using liquid chromatography-tandem mass spectrometry 63 
(LC-MS) at the Broad Institute of MIT and Harvard University. Details of metabolite profiling 64 
methods have been published previously.5 Age and multivariable-adjusted linear regressions 65 
were performed and percentage differences in levels of glutamate, glutamine, and 66 
glutamate/glutamine ratio between sunburn susceptibility groups were calculated using the 67 
following equation: [exp (β-coefficient) − 1] × 100%. All analyses were performed using SAS 68 
(Unix 9.4) 69 
3 
 
Characteristics of participants by quintiles of glutamate/glutamine ratio are presented in 70 
Table 1. We found a significant decreasing trend of glutamine [painful burn with blisters vs. 71 
reference: -9.2% (-16.9%, -0.7%), P-trend=0.005], and significant increasing trends of glutamate 72 
[painful burn with blisters vs. reference: 19.9% (10.0%, 30.7%), P-trend<0.0001] as well as 73 
glutamate/glutamine ratio [painful burn with blisters vs. reference: 22.8% (12.6%, 33.8%), P-74 
trend<0.0001] across sunburn susceptibility groups (Table 2). The association patterns were 75 
consistent and significant in the sensitivity analysis of controls-only samples [n=4,672; painful 76 
burn with blisters vs. reference: 13.4% (0.6%, 27.8%) for glutamate, -11.8% (-22.1%, -0.2%) for 77 
glutamine, 15.6% (2.6%, 30.2%) for glutamate/glutamine ratio]. We did not find significant 78 
interactions of sunburn susceptibility and selected covariates (i.e., age, smoking, body mass 79 
index, physical activity, alcohol consumption, Alternate Healthy Eating Index and personal 80 
history of diabetes, cardiovascular diseases or hypercholesterolemia in relation to plasma 81 
glutamate/glutamine ratio (all P-interaction > 0.05/7) (Table S1). 82 
Overall, our study found that being susceptible to sunburn, especially painful burn with 83 
blisters, was associated with higher glutamate and lower glutamine in plasma among cancer-free 84 
participants. Although several limitations are acknowledged, such as the women-only and cross-85 
sectional study design, this is the first study demonstrating a potential association between 86 
sunburn susceptibility (a highly heritable trait and melanoma risk factor) and plasma 87 
glutamate/glutamine (a target of anti-melanoma therapy). Additionally, our epidemiologic 88 
findings provide evidence for future investigations in terms of whether glutamatergic signaling is 89 
a potential underlying pathway by which sunburn susceptibility alters melanoma risk. Further 90 
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Table 1. Characteristics of 9,129 cancer-free participants from NHS I and II 129 
by quintiles of plasma glutamate/glutamine ratio1 130 
 131 
Characteristics Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 
Number of participants 1825 1826 1826 1826 1826 
Age at blood collection, years 51.5 (8.0) 52.0 (8.3) 52.7 (8.7) 53.5 (8.6) 53.1 (8.5) 
Plasma glutamate level, z-score -1.1 (0.5) -0.5 (0.5) -0.1 (0.5) 0.4 (0.5) 1.3 (0.8) 
Plasma glutamine level, z-score 0.5 (0.9) 0.2 (0.9) 0.1 (0.9) -0.2 (0.9) -0.6 (1.0) 
Plasma glutamate/glutamine ratio, z-score -1.3 (0.3) -0.6 (0.1) -0.1 (0.1) 0.5 (0.2) 1.5 (0.6) 
Painful burn or blistering after ≥2h sun exposure, % 13.5 15.1 18.2 20.2 21.3 
Red or blonde hair, %2 14.8 16.1 15.6 17.8 17.7 
≥6 moles on the extremity, %3 8.8 11.6 12.8 13.0 10.8 
Average July noon-time erythemal UV, mW/m2 188.7 (29.4) 190.1 (29.2) 189.8 (28.9) 192.6 (30.5) 191.4 (30.2) 
Body mass index, kg/m2 23.7 (3.5) 24.6 (4.2) 25.8 (4.7) 26.8 (5.3) 27.8 (6.1) 
Physical activity, metabolic equivalents, hours/wk 17.1 (18.8) 17.5 (25.7) 15.7 (19.1) 17.0 (25.8) 15.2 (18) 
Cigarette smoking 
    Never smoker, % 58.1 55.6 52.5 51.0 46.7 
    Past smoker, % 31.5 33.4 35.3 35.9 40.3 
    Current smoker, % 10.4 10.9 12.2 13.1 13.0 
Alcohol intake, g/d 4.6 (7.8) 5 (9.0) 5.2 (9.3) 5.6 (10.2) 5.2 (9.4) 
Alternate healthy eating index 46.6 (10.0) 46.4 (10.0) 46.4 (9.6) 46.3 (9.9) 46.5 (9.7) 
History of cardiovascular diseases 0.8 0.9 1.1 0.9 1.6 
History of diabetes 0.2 0.4 1.0 2.2 5.5 
History of hypercholesterolemia 30.0 34.5 32.8 37.7 37.8 
Note: 1 Information presented was collected at the time of blood collection or at the questionnaire cycle closest to blood collection 132 
(NHS I: 1989-1990, NHS II: 1996-1999) except for otherwise noted. Values are means (SD) for continuous variables, percentages for 133 
categorical variables, and are standardized to the age distribution of the study population except for age.  134 
2 Natural color of hair at 21 and 18 was asked in NHS I and II, respectively.  135 





Table 2. Percentage differences (95% CIs) in plasma levels of glutamate, glutamine, and glutamate/glutamine ratio 139 
according to sunburn susceptibility among 9,129 cancer-free participants from NHS I and II 140 
 141 
  
None or  
some redness only Burn Painful burn 




Number of participants 5445 2042 1106 536 
Glutamate 
   Age-adjusted model 0 (ref)  4.1% (-1.1%, 9.5%)  15.2% (8.0%, 22.9%)  34.7% (23.3%, 47.1%) <0.0001 
   Multivariable-adjusted model 0 (ref)  1.7% (-3.1%, 6.8%)  7.0% (0.5%, 13.9%)  19.9% (10.0%, 30.7%) <0.0001 
Glutamine 
   Age-adjusted model 0 (ref)  -0.3% (-5.2%, 4.8%)  -8.4% (-14.1%, -2.4%)  -10.1% (-17.7%, -1.9%) 0.002 
   Multivariable-adjusted model 0 (ref)  -0.4% (-5.4%, 4.7%)  -8.0% (-13.8%, -1.8%)  -9.2% (-16.9%, -0.7%) 0.005 
Glutamate/glutamine ratio 
   Age-adjusted model 0 (ref)  4.3% (-0.8%, 9.7%)  17.7% (10.4%, 25.6%)  37.6% (26.0%, 50.3%) <0.0001 
   Multivariable-adjusted model 0 (ref)  2.0% (-2.9%, 7.1%)  9.6% (2.9%, 16.7%)  22.8% (12.6%, 33.8%) <0.0001 
Notes: Covariates adjusted in multivariable-adjusted model include continuous age, body mass index, physical activity, alcohol 142 
consumption, alternate healthy eating index, smoking status (never, past, current), fasting status, case-control status in previous nested 143 
case-control studies, history of diabetes, cardiovascular diseases or hypercholesterolemia, hair color (black/dark brown, light brown, 144 

















Supplementary Table 1. Percentage differences (95% CIs) in plasma glutamate/glutamine ratio according to sunburn susceptibility, 160 
stratified by selected covariates among all 9,129 participants 161 
 162 
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 164 
 165 
 166 
